What is it about?
This study explores how laser light can trigger the release of silibinin from a PEG–PLA polymer matrix containing silver nanoparticles. When the laser wavelength matches the nanoparticles’ surface plasmon resonance, absorbed light is converted into localized heat. This photothermal effect enhances drug release compared with non‑resonant or non‑irradiated conditions.
Featured Image
Photo by Shubham Dhage on Unsplash
Why is it important?
The work shows that tuning nanoparticle surface chemistry and optical properties enables externally controlled, on‑demand drug release. The approach is compatible with aqueous environments and relies on visible light, supporting its relevance for photothermal strategies and localized drug delivery near tumor cells.
Perspectives
The system is demonstrated at a physicochemical and materials level, without clinical extrapolation. Future work should address biological validation, dose control, long‑term stability, and translation to complex in‑vitro or in‑vivo models.
Prof. Antonio Speciale
University of Messina
Read the Original
This page is a summary of: Biocompatible silver nanoparticles embedded in a PEG–PLA polymeric matrix for stimulated laser light drug release, Journal of Nanoparticle Research, June 2016, Springer Science + Business Media,
DOI: 10.1007/s11051-016-3467-1.
You can read the full text:
Contributors
The following have contributed to this page
